EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 15, Issue 12, Pages 1677-1687
Publisher
Informa UK Limited
Online
2014-12-24
DOI
10.4161/15384047.2014.972776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells
- (2015) Sivan M. Bokobza et al. Oncotarget
- Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome
- (2014) J. Remon et al. CANCER TREATMENT REVIEWS
- EZH2 as a potential target in cancer therapy
- (2014) Michael T McCabe et al. Epigenomics
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
- (2013) Yongjie Wei et al. CELL
- Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells
- (2013) Yannick D. Benoit et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
- (2013) Leibo Xu et al. JOURNAL OF HEPATOLOGY
- The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib
- (2013) Yiyu Zou et al. Journal of Thoracic Oncology
- Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer
- (2013) Yuan-yuan Li et al. LUNG CANCER
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
- (2013) Wieslawa H. Dragowska et al. PLoS One
- Targeting Epidermal Growth Factor Receptor in the Management of Lung Cancer
- (2013) Tony S.K. Mok et al. SEMINARS IN ONCOLOGY
- Update of research on the role of EZH2 in cancer progression
- (2013) Liang Shen et al. OncoTargets and Therapy
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review
- (2012) Cheng-Bo Han et al. CANCER INVESTIGATION
- Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
- (2012) Yannick D. Benoit et al. JOURNAL OF CELLULAR PHYSIOLOGY
- p62/SQSTM1/A170: Physiology and pathology
- (2012) Masaaki Komatsu et al. PHARMACOLOGICAL RESEARCH
- Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death
- (2011) Sandrine Eimer et al. CANCER BIOLOGY & THERAPY
- The Role of Autophagy in Cancer: Therapeutic Implications
- (2011) Z. J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
- (2011) Bettina Fussbroich et al. PLoS One
- The regulation of autophagy - unanswered questions
- (2010) Y. Chen et al. JOURNAL OF CELL SCIENCE
- Autophagy: assays and artifacts
- (2010) Sandra Barth et al. JOURNAL OF PATHOLOGY
- Anti- and pro-tumor functions of autophagy
- (2009) Eugenia Morselli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epigenetics and cancer treatment
- (2009) Lasse Sommer Kristensen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
- (2008) Xiaohua Shen et al. MOLECULAR CELL
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started